5-(5-(1H-imidazol-1-yl)-3-methyl-1-phenyl-1H-pyrazol-4-yl)-7-amino-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile

ID: ALA5270268

Max Phase: Preclinical

Molecular Formula: C21H16N8O3

Molecular Weight: 428.41

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nn(-c2ccccc2)c(-n2ccnc2)c1C1C(C#N)=C(N)Oc2[nH]c(=O)[nH]c(=O)c21

Standard InChI:  InChI=1S/C21H16N8O3/c1-11-14(15-13(9-22)17(23)32-19-16(15)18(30)25-21(31)26-19)20(28-8-7-24-10-28)29(27-11)12-5-3-2-4-6-12/h2-8,10,15H,23H2,1H3,(H2,25,26,30,31)

Standard InChI Key:  MSMOXPRRTALCEH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    2.5011   -3.2097    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7866   -2.7971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0719   -3.2097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572   -2.7971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3574   -3.2097    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0721   -2.7971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7866   -3.2096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0721   -1.9719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3574   -1.5592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3574   -0.2009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3100    0.2839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1069    0.0704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4024   -0.6562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2259   -0.6562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4394    0.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7477    0.5893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0551    1.0687    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4675    1.7831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2961    1.7831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7042    2.4996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2924    3.2097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4671    3.2097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0552    2.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7700    1.0687    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0249    0.2839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8218    0.0704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572   -1.9719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0719   -1.5592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0719   -0.7342    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7866   -1.9719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7866   -1.5593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5011   -1.1468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  6  7  1  0
  8  6  2  0
  8  9  1  0
  9 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 12 16  1  0
 17 11  1  0
 18 17  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 18  2  0
 24 17  1  0
 25 24  2  0
 25 10  1  0
 25 26  1  0
 27  9  1  0
  4 27  2  0
 27 28  1  0
 28 29  2  0
 30 28  1  0
  2 30  1  0
 31  8  1  0
 31 32  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5270268

    ---

Associated Targets(non-human)

Clostridium tetani (653 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vibrio cholerae (1211 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus fumigatus (16427 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 428.41Molecular Weight (Monoisotopic): 428.1345AlogP: 0.96#Rotatable Bonds: 3
Polar Surface Area: 160.40Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.38CX Basic pKa: 5.86CX LogP: 0.56CX LogD: 0.51
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -1.83

References

1. Elattar KM, El-Khateeb AY, Hamed SE..  (2022)  Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs.,  13  (5.0): [PMID:35694689] [10.1039/d2md00076h]

Source